Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.09 and traded as low as $0.08. Elite Pharmaceuticals shares last traded at $0.09, with a volume of 181,900 shares changing hands.
The firm’s 50-day moving average is $0.09 and its 200-day moving average is $0.07.
Elite Pharmaceuticals Company Profile (OTCMKTS:ELTP)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products segments.
Featured Story: Bond
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.